Inicio>>Signaling Pathways>> Immunology/Inflammation>> Reactive Oxygen Species>>Berberine chloride hydrate

Berberine chloride hydrate

Catalog No.GC35497

El cloruro de berberina hidratado (Natural Yellow 18 cloruro hidrato) es un alcaloide que actÚa como antibiÓtico. El hidrato de cloruro de berberina induce la generaciÓn de especies reactivas de oxÍgeno (ROS) e inhibe la topoisomerasa del ADN. Propiedades antineoplÁsicas.

Products are for research use only. Not for human use. We do not sell to patients.

Berberine chloride hydrate Chemical Structure

Cas No.: 68030-18-2

Tamaño Precio Disponibilidad Cantidad
10mM (in 1mL DMSO)
52,00 $
Disponible
100mg
46,00 $
Disponible
500mg
82,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Berberine chloride hydrate is an alkaloid isolated from the Chinese herbal medicine Huanglian, as an antibiotic. Berberine chloride hydrate induces reactive oxygen species (ROS) generation and inhibits DNA topoisomerase. Antineoplastic properties[1]. ROS[1]DNA topoisomerase[1]

Berberine (1.25-160 μM; 72 hours) has potential inhibitory effects on the proliferation of four colorectal carcinoma cell lines LoVo, HCT116, SW480, and HT-29[1]. Berberine (1.25-160 μM; 24-72 hours) induces a time- and dose-dependent inhibition of LoVo cell growth[1]. LoVo cells are exposure to Berberine (10-80 μM) for 24 h. Cell cycle analysis of 40 μM Berberine-treated LoVo cells by flow cytometry shows accumulation of cells in the G2/M phase[1].Berberine (10-80 μM) suppresses cyclin B1, cdc2 and cdc25c protein expression after 24 h, especially at the dose of 80.0 μM[1]. Cell Proliferation Assay[1] Cell Line: Four colorectal carcinoma cell lines LoVo, HCT116, SW480, and HT-29

Berberine (10, 30, or 50 mg/kg/day; gastrointestinal gavage; for 10 consecutive days) inhibits the growth of human colorectal adenocarcinoma in vivo. Berberine at doses of 30 and 50 mg/kg/day taken by gastrointestinal gavage shows inhibitory rates of 33.1% and 45.3% on the human colorectal adenocarcinoma xenograft growth in nude mice[1]. Animal Model: 5-week-old BALB/c nu/nu mice with human colorectal adenocarcinoma LoVo xenografts[1]

[1]. Cai Y, et al. Berberine inhibits the growth of human colorectal adenocarcinoma in vitro and in vivo. J Nat Med. 2014 Jan;68(1):53-62.

Reseñas

Review for Berberine chloride hydrate

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Berberine chloride hydrate

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.